10 October 2016

AstraZeneca spends $64.5m buying Amgen plant

Drug company AstraZeneca purchased a biotech drug manufacturing plant on 228 acres in Longmont, spending $64.5 million buying the site from Amgen Inc. a year after purchasing another Amgen property in Boulder. AstraZeneca will use the Longmont plant in support of the Boulder drug manufacturing property, which AstraZeneca is renovating to produce its experimental bladder cancer drug, durvalumab, which was granted potential ‘breakthrough’ status by the U.S. Food & Drug Administration in February. Source Bizjournals 10/10/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).